ACRS
Aclaris Therapeutics Inc
NASDAQ: ACRS · HEALTHCARE · BIOTECHNOLOGY
$3.97
-0.50% today
Updated 2026-10-30
Market cap
$615.29M
P/E ratio
—
P/S ratio
74.86x
EPS (TTM)
$-0.58
Dividend yield
—
52W range
$2 – $7
Volume
3.2M
Aclaris Therapeutics Inc (ACRS) Insider transactions
Net insider activity
Net buying (3,951,308 shares)
Buy transactions
55
Sell transactions
45
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-08-01 | KOLBECK, ROLAND WILHELM | Chief Scientific Officer | Sale | 36,375 | — | — |
| 2026-08-01 | KOLBECK, ROLAND WILHELM | Chief Scientific Officer | Buy | 36,375 | — | — |
| 2026-08-01 | KOLBECK, ROLAND WILHELM | Chief Scientific Officer | Sale | 12,385 | $5.20 | $64402.00 |
| 2026-06-05 | SCHIFF, ANDREW N | Director | Sale | 11,580 | — | — |
| 2026-06-05 | SCHIFF, ANDREW N | Director | Buy | 11,580 | — | — |
| 2026-06-05 | MOLINEAUX, CHRISTOPHER P. | Director | Sale | 11,580 | — | — |
| 2026-06-05 | MOLINEAUX, CHRISTOPHER P. | Director | Buy | 11,580 | — | — |
| 2026-06-05 | MILANO, VINCENT | Director | Sale | 11,580 | — | — |
| 2026-06-05 | MILANO, VINCENT | Director | Buy | 11,580 | — | — |
| 2026-06-05 | MEHRA, ANAND | Director | Sale | 11,580 | — | — |
| 2026-06-05 | MEHRA, ANAND | Director | Buy | 11,580 | — | — |
| 2026-06-05 | HUMPHRIES, WILLIAM D. | Director | Sale | 11,580 | — | — |
| 2026-06-05 | HUMPHRIES, WILLIAM D. | Director | Buy | 11,580 | — | — |
| 2026-06-05 | GOWEN, MAXINE | Director | Sale | 11,580 | — | — |
| 2026-06-05 | GOWEN, MAXINE | Director | Buy | 11,580 | — | — |
| 2026-06-04 | SCHIFF, ANDREW N | Director | Buy | 42,350 | — | — |
| 2026-06-04 | SCHIFF, ANDREW N | Director | Buy | 10,987 | — | — |
| 2026-06-04 | MOLINEAUX, CHRISTOPHER P. | Director | Buy | 42,350 | — | — |
| 2026-06-04 | MOLINEAUX, CHRISTOPHER P. | Director | Buy | 10,987 | — | — |
| 2026-06-04 | MILANO, VINCENT | Director | Buy | 42,350 | — | — |
| 2026-06-04 | MILANO, VINCENT | Director | Buy | 10,987 | — | — |
| 2026-06-04 | MEHRA, ANAND | Director | Buy | 42,350 | — | — |
| 2026-06-04 | MEHRA, ANAND | Director | Buy | 10,987 | — | — |
| 2026-06-04 | HUMPHRIES, WILLIAM D. | Director | Buy | 42,350 | — | — |
| 2026-06-04 | HUMPHRIES, WILLIAM D. | Director | Buy | 10,987 | — | — |
| 2026-06-04 | GOWEN, MAXINE | Director | Buy | 42,350 | — | — |
| 2026-06-04 | GOWEN, MAXINE | Director | Buy | 10,987 | — | — |
| 2026-05-01 | HALL, JESSE WAYNE | Chief Medical Officer | Sale | 36,375 | — | — |
| 2026-05-01 | HALL, JESSE WAYNE | Chief Medical Officer | Buy | 36,375 | — | — |
| 2026-05-01 | HALL, JESSE WAYNE | Chief Medical Officer | Sale | 9,330 | $4.41 | $41145.30 |
| 2026-04-23 | LEONARD, BRADEN MICHAEL | 10% Owner | Sale | 300,000 | $4.53 | $1.36M |
| 2026-03-01 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 2,375 | — | — |
| 2026-03-01 | BALTHASER, KEVIN | Chief Financial Officer | Buy | 2,375 | — | — |
| 2026-03-01 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 677 | $2.87 | $1942.99 |
| 2026-02-03 | WALKER, NEAL | Director, CEO | Sale | 63,475 | — | — |
| 2026-02-03 | WALKER, NEAL | Director, CEO | Buy | 63,475 | — | — |
| 2026-02-03 | WALKER, NEAL | Director, CEO | Sale | 18,611 | $3.47 | $64580.17 |
| 2026-02-03 | LOEROP, JAMES | Chief Business Officer | Sale | 20,875 | — | — |
| 2026-02-03 | LOEROP, JAMES | Chief Business Officer | Buy | 20,875 | — | — |
| 2026-02-03 | LOEROP, JAMES | Chief Business Officer | Sale | 5,937 | $3.47 | $20601.39 |
| 2026-02-03 | DAVIS, HUGH M. | Director, President and COO | Sale | 18,675 | — | — |
| 2026-02-03 | DAVIS, HUGH M. | Director, President and COO | Buy | 18,675 | — | — |
| 2026-02-03 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 22,025 | — | — |
| 2026-02-03 | BALTHASER, KEVIN | Chief Financial Officer | Buy | 22,025 | — | — |
| 2026-02-03 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 6,449 | $3.47 | $22378.03 |
| 2026-02-02 | WALKER, NEAL | Director, CEO | Buy | 274,800 | — | — |
| 2026-02-02 | WALKER, NEAL | Director, CEO | Buy | 961,700 | — | — |
| 2026-02-02 | LOEROP, JAMES | Chief Business Officer | Buy | 97,700 | — | — |
| 2026-02-02 | LOEROP, JAMES | Chief Business Officer | Buy | 341,900 | — | — |
| 2026-02-02 | KOLBECK, ROLAND WILHELM | Chief Scientific Officer | Buy | 95,700 | — | — |
| 2026-02-02 | KOLBECK, ROLAND WILHELM | Chief Scientific Officer | Buy | 334,900 | — | — |
| 2026-02-02 | HALL, JESSE WAYNE | Chief Medical Officer | Buy | 98,100 | — | — |
| 2026-02-02 | HALL, JESSE WAYNE | Chief Medical Officer | Buy | 343,300 | — | — |
| 2026-02-02 | DAVIS, HUGH M. | Director, President and COO | Buy | 96,100 | — | — |
| 2026-02-02 | DAVIS, HUGH M. | Director, President and COO | Buy | 336,300 | — | — |
| 2026-02-02 | BALTHASER, KEVIN | Chief Financial Officer | Buy | 99,100 | — | — |
| 2026-02-02 | BALTHASER, KEVIN | Chief Financial Officer | Buy | 346,800 | — | — |
| 2026-02-01 | LOEROP, JAMES | Chief Business Officer | Sale | 14,750 | — | — |
| 2026-02-01 | LOEROP, JAMES | Chief Business Officer | Sale | 11,250 | — | — |
| 2026-02-01 | LOEROP, JAMES | Chief Business Officer | Sale | 7,500 | — | — |
| 2026-02-01 | LOEROP, JAMES | Chief Business Officer | Buy | 14,750 | — | — |
| 2026-02-01 | LOEROP, JAMES | Chief Business Officer | Buy | 11,250 | — | — |
| 2026-02-01 | LOEROP, JAMES | Chief Business Officer | Sale | 10,686 | $3.51 | $37507.86 |
| 2026-02-01 | LOEROP, JAMES | Chief Business Officer | Buy | 7,500 | — | — |
| 2026-02-01 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 14,750 | — | — |
| 2026-02-01 | BALTHASER, KEVIN | Chief Financial Officer | Buy | 14,750 | — | — |
| 2026-02-01 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 4,984 | $3.51 | $17493.84 |
| 2026-01-02 | WALKER, NEAL | Director, CEO | Sale | 29,150 | — | — |
| 2026-01-02 | WALKER, NEAL | Director, CEO | Buy | 29,150 | — | — |
| 2026-01-02 | WALKER, NEAL | Director, CEO | Sale | 9,952 | $2.88 | $28661.76 |
| 2026-01-02 | LOEROP, JAMES | Chief Business Officer | Sale | 18,150 | — | — |
| 2026-01-02 | LOEROP, JAMES | Chief Business Officer | Buy | 18,150 | — | — |
| 2026-01-02 | LOEROP, JAMES | Chief Business Officer | Sale | 6,171 | $2.88 | $17772.48 |
| 2026-01-02 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 13,200 | — | — |
| 2026-01-02 | BALTHASER, KEVIN | Chief Financial Officer | Buy | 13,200 | — | — |
| 2026-01-02 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 4,461 | $2.88 | $12847.68 |
| 2026-01-01 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 7,500 | — | — |
| 2026-01-01 | BALTHASER, KEVIN | Chief Financial Officer | Buy | 7,500 | — | — |
| 2026-01-01 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 2,250 | $3.01 | $6772.50 |
| 2025-12-31 | LOEROP, JAMES | Chief Business Officer | Sale | 73,750 | — | — |
| 2025-12-31 | LOEROP, JAMES | Chief Business Officer | Buy | 73,750 | — | — |
| 2025-12-31 | LOEROP, JAMES | Chief Business Officer | Sale | 33,994 | $3.01 | $102321.94 |
| 2025-12-31 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 73,750 | — | — |
| 2025-12-31 | BALTHASER, KEVIN | Chief Financial Officer | Buy | 73,750 | — | — |
| 2025-12-31 | BALTHASER, KEVIN | Chief Financial Officer | Sale | 19,934 | $3.01 | $60001.34 |
| 2025-12-02 | DAVIS, HUGH M. | Director, President and COO | Sale | 26,750 | — | — |
| 2025-12-02 | DAVIS, HUGH M. | Director, President and COO | Buy | 26,750 | — | — |
| 2025-08-01 | KOLBECK, ROLAND WILHELM | Chief Scientific Officer | Buy | 145,500 | — | — |
| 2025-08-01 | KOLBECK, ROLAND WILHELM | Chief Scientific Officer | Buy | 510,000 | — | — |
| 2025-06-06 | SCHIFF, ANDREW N | Director | Sale | 4,793 | — | — |
| 2025-06-06 | SCHIFF, ANDREW N | Director | Buy | 4,793 | — | — |
| 2025-06-06 | MOLINEAUX, CHRISTOPHER P. | Director | Sale | 4,793 | — | — |
| 2025-06-06 | MOLINEAUX, CHRISTOPHER P. | Director | Buy | 4,793 | — | — |
| 2025-06-06 | MILANO, VINCENT | Director | Sale | 4,793 | — | — |
| 2025-06-06 | MILANO, VINCENT | Director | Buy | 4,793 | — | — |
| 2025-06-06 | MEHRA, ANAND | Director | Sale | 4,793 | — | — |
| 2025-06-06 | MEHRA, ANAND | Director | Buy | 4,793 | — | — |
| 2025-06-06 | HUMPHRIES, WILLIAM D. | Director | Sale | 4,793 | — | — |
| 2025-06-06 | HUMPHRIES, WILLIAM D. | Director | Buy | 4,793 | — | — |
| 2025-06-06 | GOWEN, MAXINE | Director | Sale | 4,793 | — | — |
Frequently asked questions
Are ACRS insiders buying or selling?
Over the transactions on record, ACRS insiders have been net buyers, with about $1.86M in stock sold across 45 sales. The entries tagged as buys are stock grants and option exercises recorded at $0, not open-market purchases.
Does insider selling at ACRS mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which ACRS insiders are selling the most?
Recent selling is concentrated in a few names. LEONARD, BRADEN MICHAEL accounts for the largest share on record, with about $1.36M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.